Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TBPH compared with AIV: revenue, margins and what each company keeps, and the suppliers and customers both name
TBPH
Theravance Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
AIV
Apartment Investment & Management Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
TBPH
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±6.0%
▼
−0.12%
×0.02
May 7 '26
±10.3%
▲
+0.47%
×0.05
Q1 FY26
±12.0%
▲
+1.30%
×0.11
Q3 FY25
±24.6%
▲
+22.68%
×0.92
AIV
No earnings history for AIV.
= implied
TBPH realized, solid
AIV realized, hatched
One scale, both sides: full bar = 25%
× = |realized| ÷ implied
Source: market data
TBPH
Theravance Biopharma, Inc.
Change
17.03
· pre 17.04
· delayed
Mkt cap
$884.2M
Revenue
$21M
Q2 FY26
Revenue
$107M
FY25
AIV
Apartment Investment & Management Co
Change
1.57
· pre 1.57
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$228.0M
Revenue
$35M
Q3 FY25
Revenue
$138M
FY24
vs
Compare
Pre-market
Oct 30 '26
delayed
TBPH
Theravance Biopharma, Inc.
vs
AIV
Apartment Investment & Management Co
17.03
pre 17.04
delayed
Price
1.57
pre 1.57
delayed
$884.2M
Mkt cap
$228.0M
Q2 FY26
$21M
Revenue
$35M
Q3 FY25
FY25
$107M
Revenue
$138M
FY24
Change
Change
TBPH
17.03
vs
AIV
1.57
Pre-market
Oct 30 '26
delayed